This confirmed the expression of MiR17hg, SNHG6, H19 and Pvt1 in glioma-infiltrating immune cells, consistent with our murine models (Fig. 2E, Supplementary Fig. 4A). The gene discussed is PVT1; the disease is central nervous system cancer.